Member Info for The-Hat

People just need to stop selling...think it will finish blue..RNS is good. Does with out research getting scared and selling into it/

Wish I had the funds to top-up. A great RNS, 4D got what they wanted from the trial, now they will move into Phase 3, were not done here yet and this is only one product.

What more were people looking for form RNS??
Snippets rom RNS,
Phase II trial results provide strong foundation for the continued development of the first therapeutic with potential to treat both major subtypes of IBS
Blautix® has potential to treat both major subtypes of the disease, unlike other approved products which act only on symptoms associated with either subtype of IBS
The randomised Phase II study was designed to generate data to guide the pivotal development phase of the Blautix® program and the results shown give the Company confidence and the necessary data for the design of a Phase III pivotal programme.
The Company is currently undertaking further analysis of the study results, including investigation of sub-groups with signals of higher levels of overall response, in order to define the future pivotal clinical development strategy.

*825k

Anyone know?

I got 103

Not far behind you @ 20p here on a free ride now. : )

It's Regeneron.. they have their own mice.

Either that or a speeding ticket, we know how they like those. No speeding ticket means fuse is lit for Monday. imo of course.

Lilly will manufacture a batch for trials..HEMO do not do manufacturing and it is not something you can put in place quickly. Lilly may have already been working on this in the background if they felt it was a goer...saves time and time is money.

Lilly must want to do a deal otherwise why would discussions be ongoing. If they didn't want to licence we would have had an RNS by now to that effect. Lilly deal is only a matter of time imo, what have HEMO got to gain by walking away from it?

RNS might land after hours.

83k for me, will top up to 100k once funds are available

I agree. No news is good news at this point.

The extension is only for completion of study. Do they have have 3 months to take up licencing deal after completion? IIRC from webinar? I stand to be corrected?

Reads very well, I knew the potential, some of those comparison deals are massive. Go HEMO.

I was thinking (hoping) ODX as well.

VOX were slow on this too..at least for me...alert never appeared...only when I refreshed.

NCYT just got an RNS because care home testing with their kit was leaked.
Wonder will there be one incoming here?

This is the leg up we need..first of many.